Construction of a new Transtuzumab-marine drug ADC

Summary
The ADC will be prepared via Transtuzumab-marine drug (PharmaMar) conjugation based on Cys site selective modification.
More information & hyperlinks
Web resources: https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5be7a8aa4&appId=PPGMS
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Associated projects
Organisations
  • Not specified
Powered by Chris Decubber BV